Rituximab-IgG2 is a phagocytic enhancer in antibody-based immunotherapy of B-cell lymphoma by altering CD47 expression
Oanh T. P. Nguyen(Uppsala University), Sandra Kleinau(Uppsala University)
Cited by 2
Related Papers
No related papers found
Powered by citation graph analysis